163 related articles for article (PubMed ID: 30477373)
1. Risk factors for acute liver failure among inpatients with anti-tuberculosis drug-induced liver injury.
Wang S; Shangguan Y; Ding C; Li P; Ji Z; Shao J; Fang H; Yang M; Shi P; Wu J; Ren J; Yang S; Yuan J; Shi Y; Li J; Li L; Xu K
J Int Med Res; 2020 Jan; 48(1):300060518811512. PubMed ID: 30477373
[TBL] [Abstract][Full Text] [Related]
2. Acute liver failure due to antitubercular therapy: Strategy for antitubercular treatment before and after liver transplantation.
Ichai P; Saliba F; Antoun F; Azoulay D; Sebagh M; Antonini TM; Escaut L; Delvart V; Castaing D; Samuel D
Liver Transpl; 2010 Oct; 16(10):1136-46. PubMed ID: 20879012
[TBL] [Abstract][Full Text] [Related]
3. Incidence of antituberculosis-drug-induced hepatotoxicity and associated risk factors among tuberculosis patients in Dawro Zone, South Ethiopia: A cohort study.
Wondwossen Abera ; Waqtola Cheneke ; Gemeda Abebe
Int J Mycobacteriol; 2016 Mar; 5(1):14-20. PubMed ID: 26927985
[TBL] [Abstract][Full Text] [Related]
4. Baseline HBV load increases the risk of anti-tuberculous drug-induced hepatitis flares in patients with tuberculosis.
Zhu CH; Zhao MZ; Chen G; Qi JY; Song JX; Ning Q; Xu D
J Huazhong Univ Sci Technolog Med Sci; 2017 Feb; 37(1):105-109. PubMed ID: 28224437
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and risk factors of anti-tuberculosis drug-induced hepatitis in Malaysia.
Marzuki OA; Fauzi AR; Ayoub S; Kamarul Imran M
Singapore Med J; 2008 Sep; 49(9):688-93. PubMed ID: 18830542
[TBL] [Abstract][Full Text] [Related]
6. Drug-induced acute liver failure in children and adults: Results of a single-centre study of 128 patients.
Devarbhavi H; Patil M; Reddy VV; Singh R; Joseph T; Ganga D
Liver Int; 2018 Jul; 38(7):1322-1329. PubMed ID: 29222960
[TBL] [Abstract][Full Text] [Related]
7. Antituberculosis therapy drug-induced liver injury and acute liver failure.
Devarbhavi H; Dierkhising R; Kremers WK
Hepatology; 2010 Aug; 52(2):798-9; author reply 799-800. PubMed ID: 20683973
[No Abstract] [Full Text] [Related]
8. Co-infection with hepatitis B virus among tuberculosis patients is associated with poor outcomes during anti-tuberculosis treatment.
Chen L; Bao D; Gu L; Gu Y; Zhou L; Gao Z; Huang Y
BMC Infect Dis; 2018 Jul; 18(1):295. PubMed ID: 29970037
[TBL] [Abstract][Full Text] [Related]
9. Impact of emergency adult living donor liver transplantation on the survival of patients with antituberculosis therapy-induced acute liver failure.
Huh JY; Lee D; Ahn J; Shim JH; Lim YS; Park GC; Song GW; Kim KH; Jung DH; Moon DB; Hwang S; Lee SG; Lee SW; Song JW; Oh YM; Shim TS; Jo KW
Liver Transpl; 2017 Jun; 23(6):845-846. PubMed ID: 28006868
[No Abstract] [Full Text] [Related]
10. Drug-induced liver injury in hospitalized HIV patients: high incidence and association with drugs for tuberculosis.
Tomich LG; Núñez M; Mendes-Correa MC
Ann Hepatol; 2015; 14(6):888-94. PubMed ID: 26436361
[TBL] [Abstract][Full Text] [Related]
11. Antituberculosis drug-induced liver injury in chronic hepatitis and cirrhosis.
Park WB; Kim W; Lee KL; Yim JJ; Kim M; Jung YJ; Kim NJ; Kim DH; Kim YJ; Yoon JH; Oh MD; Lee HS
J Infect; 2010 Oct; 61(4):323-9. PubMed ID: 20670648
[TBL] [Abstract][Full Text] [Related]
12. [Survey of anti-tuberculosis drug-induced severe liver injury in Japan].
Shigeto E;
Kekkaku; 2007 May; 82(5):467-73. PubMed ID: 17564126
[TBL] [Abstract][Full Text] [Related]
13. Liver transplantation for acute liver failure due to antitubercular drugs - a single-center experience.
Martino RB; Abdala E; Villegas FC; D'Albuquerque LAC; Song ATW
Clinics (Sao Paulo); 2018 Jul; 73():e344. PubMed ID: 30020340
[TBL] [Abstract][Full Text] [Related]
14. [A case of the successful treatment of drug-induced toxic hepatitis in a child with tuberculous meningoencephalitis].
Kalugin AV; Kolesnikova IV; Zhuravleva LIu; Churiumova OG; Maĭorov VM
Anesteziol Reanimatol; 1998; (1):68-9. PubMed ID: 9553268
[No Abstract] [Full Text] [Related]
15. Antituberculous drug-induced liver injury: current perspective.
Devarbhavi H
Trop Gastroenterol; 2011; 32(3):167-74. PubMed ID: 22332331
[TBL] [Abstract][Full Text] [Related]
16. [Fulminant hepatitis].
Yasuda H; Yoshiba S
Nihon Rinsho; 2007 Oct; 65 Suppl 8():545-8. PubMed ID: 18074599
[No Abstract] [Full Text] [Related]
17. [Secular increase in the incidence rate of drug-induced hepatitis due to anti-tuberculosis chemotherapy including isoniazid and rifampicin].
Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H; Mohri M
Kekkaku; 2003 Apr; 78(4):339-46. PubMed ID: 12739393
[TBL] [Abstract][Full Text] [Related]
18. Risk assessment of hepatotoxicity among tuberculosis and human immunodeficiency virus/AIDS-coinfected patients under tuberculosis treatment.
Ngouleun W; Biapa Nya PC; Pieme AC; Telefo PB
Int J Mycobacteriol; 2016 Dec; 5(4):482-488. PubMed ID: 27931691
[TBL] [Abstract][Full Text] [Related]
19. Single-center experience with drug-induced liver injury from India: causes, outcome, prognosis, and predictors of mortality.
Devarbhavi H; Dierkhising R; Kremers WK; Sandeep MS; Karanth D; Adarsh CK
Am J Gastroenterol; 2010 Nov; 105(11):2396-404. PubMed ID: 20648003
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis C and not Hepatitis B virus is a risk factor for anti-tuberculosis drug induced liver injury.
Kim WS; Lee SS; Lee CM; Kim HJ; Ha CY; Kim HJ; Kim TH; Jung WT; Lee OJ; Hong JW; You HS; Cho HC
BMC Infect Dis; 2016 Feb; 16():50. PubMed ID: 26833347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]